NCT00855569

Brief Summary

The rationale underlying the study is that donor site bleeding is common and often problematic when presenting to the burn surgeon or staff. Frequently, gauze wound dressings are not sufficiently hemostatic to control a donor site bleed thereby leading to administration of vasoconstrictive agents and repeated application of wound dressing/pressure. The hemostatic textile Stasilon™ has proven superior to gauze in reducing bleeding from anesthetized pigs undergoing standardized surgically-induced trauma. Also, observational case reports have noted cessation of bleeding in a limited number of human patients with difficult to control bleeds.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 4, 2009

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

December 12, 2017

Status Verified

June 1, 2012

Enrollment Period

2.3 years

First QC Date

March 2, 2009

Last Update Submit

December 8, 2017

Conditions

Keywords

allografting

Outcome Measures

Primary Outcomes (1)

  • To compare the efficacy of a new hemostatic textile named Stasilon™ against standard wound dressings in controlling burn patient donor graft site bleeding.

    At the time of surgery

Study Arms (1)

1

Each donor site will act as it own control - both dressings will be applied to the donor site and assessments will be made

Device: Stasilon

Interventions

StasilonDEVICE

Stasilon and gauze will be applied to donor site. Dressings will be collected and evaluated for amount of shed blood.

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients admitted to the UNC Jaycee Burn Center

You may qualify if:

  • \>/= 18 years old
  • burn injury requiring allografting from donor site

You may not qualify if:

  • \< 18 years
  • unable to give consent due to mental or emotional instability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Carolina Jaycee Burn Center

Chapel Hill, North Carolina, 27514, United States

Location

MeSH Terms

Conditions

Wounds and Injuries

Study Officials

  • Preston Rich, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2009

First Posted

March 4, 2009

Study Start

June 1, 2008

Primary Completion

September 1, 2010

Study Completion

December 1, 2010

Last Updated

December 12, 2017

Record last verified: 2012-06

Locations